Can people on cardiac medicine take albendazole
Reading File
Finding Sources
Searching PubMed
albendazole drug interactions cardiac medications
Searching the Web
albendazole drug interactions cardiac medications safety
Reading File
Reading File
Reading Web Page
https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/02…
I now have comprehensive information to give a detailed, well-sourced answer.
Albendazole and Cardiac Medications: Key Considerations
In most cases, people on cardiac medications can take albendazole, especially at the standard single dose used for routine worm infections (400 mg). However, there are several specific interactions and cautions worth knowing, depending on which cardiac drug is involved.
1. Theophylline (used in some cardiac/respiratory conditions)
This is the most clinically significant interaction. Albendazole induces cytochrome P450 1A (CYP1A) in the liver. Since theophylline is metabolized by CYP1A2, albendazole can increase theophylline metabolism and potentially alter its plasma levels. The FDA prescribing information for Albenza recommends that theophylline plasma concentrations be monitored during and after albendazole treatment.
2. No major direct interactions with most cardiac drugs
Albendazole's formally documented drug interactions (per FDA labeling and Goodman & Gilman) are:
- Dexamethasone: raises albendazole sulfoxide levels ~56%
- Praziquantel: raises albendazole sulfoxide levels ~50%
- Cimetidine: ~2-fold increase in bile/cystic fluid concentrations
- Theophylline: CYP1A induction (monitor levels)
Most standard cardiac drugs - beta-blockers, ACE inhibitors, ARBs, statins, antiplatelet agents, most antihypertensives - are not listed as interacting with albendazole in pharmacology references including Goodman & Gilman and Goldman-Cecil Medicine.
3. Warfarin / Anticoagulants - watch closely
While not in Albenza's formal labeling as a named interaction, albendazole's CYP-inducing effects can theoretically affect anticoagulants metabolized by CYP enzymes. Clinically, INR monitoring is advisable in patients on warfarin who are given albendazole, particularly at higher doses or prolonged courses.
4. Hepatic Caution - relevant for many cardiac patients
Albendazole is hepatically metabolized, and elevated liver enzymes occur in up to 16% of patients on higher doses. Many cardiac patients (especially those on statins, amiodarone, or with heart failure) may already have compromised hepatic function. Per Goldman-Cecil Medicine, albendazole should be used cautiously in those with compromised hepatic function, with liver function monitoring before each cycle and every 2 weeks during long-term therapy.
5. Amiodarone - theoretical concern
Amiodarone is a potent inhibitor of multiple CYP enzymes (including CYP3A4, CYP2D6) and is itself hepatotoxic. While no specific study documents this interaction, concurrent use deserves extra hepatic monitoring, as both drugs have hepatotoxic potential.
6. Heart failure patients
There are no direct contraindications, but patients with heart failure often have hepatic congestion, which can increase albendazole levels (biliary excretion is its primary route; obstruction raises serum concentrations). Extra caution is warranted with higher-dose, prolonged regimens.
Practical Summary
| Cardiac Drug Class | Interaction with Albendazole | Action |
|---|---|---|
| Beta-blockers, ACE inhibitors, ARBs | No significant interaction | Standard use |
| Statins | Theoretical additive hepatotoxicity at high doses | Monitor LFTs with prolonged use |
| Warfarin | Possible CYP-mediated effect | Monitor INR |
| Theophylline | CYP1A induction - levels may be altered | Monitor drug levels |
| Amiodarone | Both hepatotoxic; CYP interactions | Monitor LFTs |
| Digoxin, calcium channel blockers | No documented direct interaction | Standard use |
For a standard single-dose treatment (e.g., 400 mg once for intestinal worms), the risk in cardiac patients is very low. For prolonged, high-dose regimens (neurocysticercosis, echinococcosis), closer monitoring of liver function and relevant drug levels is needed.
Always advise the patient to inform their prescribing physician of all current medications before starting albendazole, so individual drug-drug interactions can be assessed.
Sources: Goldman-Cecil Medicine (p. 3389), Goodman & Gilman's Pharmacological Basis of Therapeutics (p. 1345), FDA Albenza prescribing information (2019)
This is a shared conversation. Sign in to Orris to start your own chat.